InvestorsHub Logo
Followers 28
Posts 6019
Boards Moderated 0
Alias Born 10/30/2013

Re: bow-tie post# 23009

Saturday, 02/06/2021 11:36:45 PM

Saturday, February 06, 2021 11:36:45 PM

Post# of 27659
eTheRNA Lipid Nanoparticles


eTheRNA immunotherapies 2 days ago

Today is World Cancer day! Here at eTheRNA, we are working on developing mRNA-based vaccines to fight against multiple cancers.

Learn more: https://lnkd.in/ei7mUGi

#worldcancerday #mrna #immunotherapy #cancer


You mean Lipid Nonoparticles Among the colloidal carriers, nanolipid dispersions (liposomes, deformable liposomes, virosomes, ethosomes, and solid lipid nanoparticles) are ideal delivery systems with the advantages of biodegradation and nontoxicity.

HPV+ cancer

eTheRNA is developing an mRNA-based vaccine against HPV+ Head and neck cancer consisting of mRNA encoding for TriMix and E6/E7 antigens packaged in lipid nanoparticles administered intravenously.
Currently, a candidate is being tested in preclinical studies.

Kidney cancer

eTheRNA, in collaboration with Frame Therapeutics, is developing a mRNA-based vaccine against kidney cancer consisting of mRNA encoding for TriMix and frame shift neo-antigens packaged in lipid nanoparticles that will be administered intravenously.



https://www.etherna.be/immunotherapies-rd-pipeline-immunostimulation/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News